From the micro to the macro to improve health: microorganism ecology and society in teaching infectious disease epidemiology.


Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
06 2020
Historique:
received: 06 06 2019
revised: 14 02 2020
accepted: 18 02 2020
pubmed: 11 5 2020
medline: 28 8 2020
entrez: 11 5 2020
Statut: ppublish

Résumé

Chronic and emerging infectious diseases and antimicrobial resistance remain a substantial global health threat. Microbiota are increasingly recognised to play an important role in health. Infections also have a profound effect beyond health, especially on global and local economies. To maximise health improvements, the field of infectious disease epidemiology needs to derive learning from ecology and traditional epidemiology. New methodologies and tools are transforming understanding of these systems, from a better understanding of socioeconomic, environmental, and cultural drivers of infection, to improved methods to detect microorganisms, describe the immunome, and understand the role of human microbiota. However, exploiting the potential of novel methods to improve global health remains elusive. We argue that to exploit these advances a shift is required in the teaching of infectious disease epidemiology to ensure that students are well versed in a breadth of disciplines, while maintaining core epidemiological skills. We discuss the following key points using a series of teaching vignettes: (1) integrated training in classic and novel techniques is needed to develop future scientists and professionals who can work from the micro (interactions between pathogens, their cohabiting microbiota, and the host at a molecular and cellular level), with the meso (the affected communities), and to the macro (wider contextual drivers of disease); (2) teach students to use a team-science multidisciplinary approach to effectively integrate biological, clinical, epidemiological, and social tools into public health; and (3) develop the intellectual skills to critically engage with emerging technologies and resolve evolving ethical dilemmas. Finally, students should appreciate that the voices of communities affected by infection need to be kept at the heart of their work.

Identifiants

pubmed: 32386611
pii: S1473-3099(20)30136-5
doi: 10.1016/S1473-3099(20)30136-5
pmc: PMC7252039
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e142-e147

Subventions

Organisme : Wellcome Trust
ID : 082384/Z/07/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL131049
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health
ID : NF-SI-0616-10037
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH114560
Pays : United States
Organisme : Wellcome Trust
ID : 210479/Z/18/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Science. 2014 Sep 12;345(6202):1369-72
pubmed: 25214632
Lancet. 2007 Dec 15;370(9604):2044-53
pubmed: 18063027
Lancet HIV. 2018 Nov;5(11):e656-e666
pubmed: 30174214
PLoS One. 2018 Dec 7;13(12):e0208167
pubmed: 30532210
J Health Soc Behav. 1995;Spec No:80-94
pubmed: 7560851
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
Lancet. 2008 Nov 8;372(9650):1661-9
pubmed: 18994664
ACS Infect Dis. 2019 Apr 12;5(4):493-505
pubmed: 30857388
Sex Transm Infect. 2006 Oct;82(5):368-71
pubmed: 16854995
Lancet HIV. 2019 Jan 1;6(1):e60-e66
pubmed: 32066995
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Trans R Soc Trop Med Hyg. 1989;83 Suppl:25-9
pubmed: 2576161
Lancet. 2016 Nov 19;388(10059):2510-2518
pubmed: 27742165
Nature. 2016 Oct 12;538(7624):193-200
pubmed: 27734858
Am J Public Health. 2016 Oct;106(10):1865-71
pubmed: 27552267
Vaccine. 2018 May 31;36(23):3221-3230
pubmed: 29724506
Lancet. 2015 Nov 14;386(10007):1973-2028
pubmed: 26188744
Nat Rev Genet. 2018 May;19(5):299-310
pubmed: 29479082
BMJ. 2004 Apr 24;328(7446):977-80
pubmed: 15066887
Soc Sci Med. 1997 Jul;45(2):273-81
pubmed: 9225414
JAMA. 2006 Oct 11;296(14):1742-8
pubmed: 17032987
Vaccine. 2017 Jun 22;35(29):3621-3638
pubmed: 28554500
Lancet. 2018 Oct 13;392(10155):1349-1357
pubmed: 30322585
Transbound Emerg Dis. 2013 Nov;60 Suppl 2:4-13
pubmed: 24589096
Malar J. 2017 Jan 5;16(1):16
pubmed: 28056979
Genet Epidemiol. 2009 Nov;33(7):581-98
pubmed: 19278015
Ann Epidemiol. 2015 Jun;25(6):458-65
pubmed: 25976024
Gut. 2018 Sep;67(9):1716-1725
pubmed: 29934437
Lancet Infect Dis. 2015 Aug;15(8):913-21
pubmed: 25936611
Nat Hum Behav. 2018 Nov;2(11):808-815
pubmed: 31457107
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8252-8259
pubmed: 30082409
Curr Opin Chem Biol. 2013 Feb;17(1):1-3
pubmed: 23395431
Sci Rep. 2018 Sep 18;8(1):13963
pubmed: 30228285
Lancet Infect Dis. 2014 Apr;14(4):341-52
pubmed: 24631223
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Int J Epidemiol. 2009 Aug;38(4):1008-16
pubmed: 19261659
Nat Rev Gastroenterol Hepatol. 2012 Sep 04;9(10):577-89
pubmed: 22945443
J Hum Hypertens. 2002 Nov;16(11):761-70
pubmed: 12444537
JMIR Form Res. 2019 Apr 04;3(2):e11342
pubmed: 30946016
Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):609-14
pubmed: 22890109
Am J Epidemiol. 2019 May 1;188(5):818-824
pubmed: 30877296
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6689-94
pubmed: 27247405
J Investig Med. 2012 Jun;60(5):768-75
pubmed: 22525233
Nature. 2014 Mar 6;507(7490):S2-3
pubmed: 24611167
Lancet Respir Med. 2014 Jun;2(6):445-54
pubmed: 24717637

Auteurs

Maryam Shahmanesh (M)

Institute for Global Health, University College London, London, UK; Africa Health Research Institute, Durban, South Africa. Electronic address: m.shahmanesh@ucl.ac.uk.

Guy Harling (G)

Institute for Global Health, University College London, London, UK; Africa Health Research Institute, Durban, South Africa; MRC/Wits-Agincourt Unit, University of the Witwatersrand, Johannesburg, South Africa; Harvard Centre for Population and Development Studies, Harvard T H Chan School of Public Health, Boston, MA, USA.

Cordelia E M Coltart (CEM)

Institute for Global Health, University College London, London, UK.

Heather Bailey (H)

Institute for Global Health, University College London, London, UK.

Carina King (C)

Institute for Global Health, University College London, London, UK; Department of Public Health Sciences, Karolinska Institutet, Solna, Sweden.

Jo Gibbs (J)

Institute for Global Health, University College London, London, UK.

Janet Seeley (J)

Africa Health Research Institute, Durban, South Africa; London School of Hygiene and Tropical Medicine, London, UK.

Andrew Phillips (A)

Institute for Global Health, University College London, London, UK.

Caroline A Sabin (CA)

Institute for Global Health, University College London, London, UK.

Robert W Aldridge (RW)

Institute of Health Informatics, University College London, London, UK.

Pam Sonnenberg (P)

Institute for Global Health, University College London, London, UK.

Graham Hart (G)

Institute for Global Health, University College London, London, UK.

Mike Rowson (M)

Institute for Global Health, University College London, London, UK.

Deenan Pillay (D)

Division of infection and immunity, University College London, London, UK; Africa Health Research Institute, Durban, South Africa.

Anne M Johnson (AM)

Institute for Global Health, University College London, London, UK.

Ibrahim Abubakar (I)

Institute for Global Health, University College London, London, UK.

Nigel Field (N)

Institute for Global Health, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH